The statements and guidelines EASD is involved in have significant visibility and have, particularly concerning statements on treatment and diagnostic criteria, substantial impact on health care politics.
Therefore, the Committee on Clinical Affairs (CCA), chaired by Prof. David R. Matthews, is responsible for structuring and overseeing EASD’s activities in the development of formal statements and guidelines.
The mission of the CCA is to ensure that any guideline or statement which is produced and/or endorsed by EASD is appropriate, non-contradictory and consistent with current research findings and best practice in diabetes management.
This supports the EASD mission of promoting excellence in diabetes care through research and education and the stated aims of the Association to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application.
The role of CCA is to advise the EASD Board on all matters concerning guidelines and statements. The Committee will:
Evaluate all initial requests from members of the Association or other institutions or societies concerning the development of guidelines and statements and advise the Executive Committee accordingly.
Oversee all activities of the Association in the different guideline and statement committees and advise the Board accordingly.